Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoko Oka

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|March 20, 2019
Clinical effects of CD33 and MPC-1 on the prognosis of multiple myeloma treated with bortezomibSatoko Oka, Kazuo Ono, Masaharu Nohgawa
British Journal of Haematology|August 24, 2020
Paraneoplastic acute demyelinating disease with monoclonal gammopathy of unknown significance expressing aquaporin-4Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia & Lymphoma|February 9, 2019
Successful treatment with mogamulizumab of refractory/relapsed angioimmunoblastic T-cell lymphoma following autologous stem cell transplantationSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia Research Reports|December 12, 2018
Cytomegalovirus reactivation triggers the late onset of hyperthyroidism after autologous peripheral blood transplantationSatoko Oka, Kazuo Ono, Masaharu Nohgawa
International Journal of Hematology|March 13, 2020
Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypesSatoko Oka, Kazuo Ono, Masaharu Nohgawa
International Journal of Clinical Practice|February 2, 2021
The association of lymphocyte phenotypes and outcomes after discontinuing eltrombopag in immune thrombocytopeniaSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Annals of Hematology|August 9, 2022
Effective treatment with polatuzumab vedotin of relapsed and refractory primary cutaneous diffuse large B-cell lymphoma leg typeSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia & Lymphoma|August 29, 2019
Ixazomib-induced Sweet's syndromeSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Pathology Oncology Research : POR|August 24, 2019
Successful Retreatment with Elotuzumab for Multiple Myeloma with Extramedullary Relapse while Being Treated with Lenalidomide and DexamethasoneSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Internal Medicine (Tokyo, Japan)|June 11, 2019
Subclinical Hypothyroidism in TAFRO SyndromeSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|March 20, 2019
Clinical effects of CD33 and MPC-1 on the prognosis of multiple myeloma treated with bortezomibSatoko Oka, Kazuo Ono, Masaharu Nohgawa
British Journal of Haematology|August 24, 2020
Paraneoplastic acute demyelinating disease with monoclonal gammopathy of unknown significance expressing aquaporin-4Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia & Lymphoma|February 9, 2019
Successful treatment with mogamulizumab of refractory/relapsed angioimmunoblastic T-cell lymphoma following autologous stem cell transplantationSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia Research Reports|December 12, 2018
Cytomegalovirus reactivation triggers the late onset of hyperthyroidism after autologous peripheral blood transplantationSatoko Oka, Kazuo Ono, Masaharu Nohgawa
International Journal of Hematology|March 13, 2020
Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypesSatoko Oka, Kazuo Ono, Masaharu Nohgawa
International Journal of Clinical Practice|February 2, 2021
The association of lymphocyte phenotypes and outcomes after discontinuing eltrombopag in immune thrombocytopeniaSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Annals of Hematology|August 9, 2022
Effective treatment with polatuzumab vedotin of relapsed and refractory primary cutaneous diffuse large B-cell lymphoma leg typeSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia & Lymphoma|August 29, 2019
Ixazomib-induced Sweet's syndromeSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Pathology Oncology Research : POR|August 24, 2019
Successful Retreatment with Elotuzumab for Multiple Myeloma with Extramedullary Relapse while Being Treated with Lenalidomide and DexamethasoneSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Internal Medicine (Tokyo, Japan)|June 11, 2019
Subclinical Hypothyroidism in TAFRO SyndromeSatoko Oka, Kazuo Ono, Masaharu Nohgawa
Pageof 10